此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline

2026年5月8日 更新者:The Hong Kong Polytechnic University

Artificial Intelligence (AI)-Assist Sleep Intervention for Insomnia Among Older Adults With Subjective Cognitive Decline: A Pilot Randomized Controlled Trial

To assess the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline.

研究概览

详细说明

This is a two-arm pilot randomized controlled trial evaluating the feasibility and acceptability of Artificial Intelligence (AI)-assisted sleep intervention on improving the insomnia of older adults with subjective cognitive decline. Sixty participants will be rectuited. Participants in the intervention group will receive a 6-week AI-assisted sleep intervention, while those in the control group will receive usual care. Outcomes including feasibility and acceptability of the AI-assisted sleep intervention, insomnia, beliefs and attitudes of sleep, depression, and anxiety will be measured at baseline and immediately post intervention.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Guangdong
      • Qingyuan、Guangdong、中国、511800

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • older adults aged ≥ 60 years
  • Subjective cognitive decline questionnaire 9 (SCD-Q9) ≥ 5
  • Montreal Cognitive Assessment (MoCA) ≥ 26. If the number of years of education is less than 12, one point will be added to the total score;
  • with insomnia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and Insomnia Severity Index (ISI) ≥ 8
  • reachable by phone

Exclusion Criteria:

  • having a previously diagnosed primary sleep disorder, such as sleep apnoea
  • suffering from a severe chronic illness that could contribute to sleep problems (e.g., emphysema)
  • currently undergoing medical, psychological, or psychiatric treatment for sleep disturbances or depression
  • having significant visual or hearing impairments.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:日常护理
The standard care participants receive from the healthcare system and/or their daily routines to address insomnia symptoms
实验性的:Artificial Intelligence (AI)-assisted sleep intervention
Six weeks of AI-assisted sleep intervention

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Eligibility rate
大体时间:Pre-intervention
The number of screened participants who will be eligible.
Pre-intervention
Recruitment rate
大体时间:Pre-intervention
The number of participants enrolled in the study
Pre-intervention
Adherence rate
大体时间:Immediately post-intervention
The number of participants in the intervention and control groups who complete the intervention
Immediately post-intervention
Attrition rate
大体时间:Immediately post-intervention
The percentage of enrolled participants who discontinue participation at any point during the study.
Immediately post-intervention
Engagement rate
大体时间:Immediately post-intervention
The degree of mastery and use of the intervention content, measured by sleep diary data.
Immediately post-intervention
Retention rate
大体时间:Immediately post-intervention
The number of participants who remain in the study
Immediately post-intervention
Acceptability
大体时间:Immediately post-intervention
Participants' perceptions of and satisfaction with the intervention will be assessed through individual interviews.
Immediately post-intervention

次要结果测量

结果测量
措施说明
大体时间
Insomnia
大体时间:Pre-intervention and immediately post-intervention
Insomnia will be measured by Insomnia Severity Index (ISI) and actigraphy. The total score on ISI ranges from zero to 28 points, with a higher score indicating more severe insomnia. A total score between 0 and 7 indicates no clinical insomnia; a score of 8 to 14 suggests subthreshold insomnia; 15 to 21 indicates moderate insomnia; and 22 to 28 indicates severe insomnia. The actigraphy will be used in this study is Xiaomi Mi Band 10.
Pre-intervention and immediately post-intervention
Beliefs and attitudes of sleep
大体时间:Pre-intervention and immediately post-intervention
Beliefs and attitudes of sleep will be measured by the Dysfunctional Beliefs and Attitudes about Sleep Scale-16 (DBAS-16). The total score of the scale is 16-80 points. The higher the total score, the more correct the belief and attitude towards sleep.
Pre-intervention and immediately post-intervention
Depression
大体时间:Pre-intervention and immediately post-intervention
Depression will be measured by 15-item Geriatric Depression Scale (GDS-15). The total score on the scale ranges from zero to 15 points, with the total score above eight points indicating the presence of depression. Higher scores indicate more severe depression.
Pre-intervention and immediately post-intervention
Anxiety
大体时间:Pre-intervention and immediately post-intervention
Anxiety will be measured by Generalized Anxiety Disorder Scale. The total score of the scale is 0-21 points, with no anxiety below 5 points, mild anxiety of 5-9 points, moderate anxiety of 10-14 points, and severe anxiety above 14 points.Higher scores indicate more severe anxiety.
Pre-intervention and immediately post-intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年4月20日

初级完成 (估计的)

2027年9月1日

研究完成 (估计的)

2027年9月1日

研究注册日期

首次提交

2026年4月17日

首先提交符合 QC 标准的

2026年5月8日

首次发布 (实际的)

2026年5月14日

研究记录更新

最后更新发布 (实际的)

2026年5月14日

上次提交的符合 QC 标准的更新

2026年5月8日

最后验证

2026年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅